World's Best Scientists 2026 revealed!
Richard G. Wunderink

Richard G. Wunderink

D-Index & Metrics

Medicine

D-Index
100
Citations
54613
World Ranking
8132
National Ranking
4215

Overview

Richard G. Wunderink is affiliated with Northwestern University in the United States with a research focus primarily in the field of Medicine. Their work centers on key subfields including Epidemiology, Infectious Diseases, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, and Molecular Medicine.

The main topics addressed in their research reflect a concentration on respiratory and infectious conditions. These include Pneumonia and Respiratory Infections, Nosocomial Infections in ICU, Antibiotic Resistance in Bacteria, Respiratory Support and Mechanisms, COVID-19 Clinical Research Studies, Respiratory Viral Infections Research, and Antibiotics Pharmacokinetics and Efficacy.

Frequent co-authors who have collaborated with Richard G. Wunderink span several academics, highlighting ongoing research partnerships. These co-authors are:

  • Catherine A. Gao
  • Chiagozie I. Pickens
  • G. R. Scott Budinger
  • Benjamin D. Singer
  • Alexander V. Misharin

Richard G. Wunderink has multiple publications across notable journals and venues. The most common outlets for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Open Forum Infectious Diseases
  • CHEST Journal
  • Clinical Infectious Diseases

The following are selected significant recent publications authored or co-authored by Richard G. Wunderink, listed with their full titles, venues, and years of publication:

  • Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial, 2020, The Lancet Infectious Diseases
  • Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia, 2021, Nature
  • Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial, 2020, The Lancet Infectious Diseases
  • Pneumonia, 2021, Nature Reviews Disease Primers
  • Local and systemic responses to SARS-CoV-2 infection in children and adults, 2021, Nature

Best Publications

  • Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

    Lionel A. Mandell;Richard G. Wunderink;Antonio Anzueto;John G. Bartlett

  • Community-acquired pneumonia requiring hospitalization among U.S. adults

    Seema Jain;Derek J. Williams;Sandra R. Arnold;Krow Ampofo

  • International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

    Antoni Torres;Michael S Niederman;Jean Chastre;Santiago Ewig

  • Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement

    G. D. Campbell;M. S. Niederman;W. A. Broughton;D. E. Craven

  • Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial

    E Abraham;R Wunderink;H Silverman;T M Perl

  • MERS, SARS and other coronaviruses as causes of pneumonia

    Yudong Yin;Richard G. Wunderink

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

    Edward Abraham;Antonio Anzueto;Guillermo Gutierrez;Sidney Tessler

  • Linezolid vs Vancomycin: Analysis of Two Double-Blind Studies of Patients With Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia

    Richard G. Wunderink;Jordi Rello;Sue K. Cammarata;Rodney V. Croos-Dabrera

  • Noninvasive positive pressure ventilation via face mask : first-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure

    G. Umberto Meduri;Robert E. Turner;Nabil Abou-Shala;Richard Wunderink

  • Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.

    Matteo Bassetti;Roger Echols;Yuko Matsunaga;Mari Ariyasu

  • Angiotensin II for the Treatment of Vasodilatory Shock.

    Ashish Khanna;Shane W. English;Xueyuan S. Wang;Kealy Ham

  • Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

    Richard G. Wunderink;Michael S. Niederman;Marin H. Kollef;Andrew F. Shorr

  • Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

    Mitchell P. Fink;David R. Snydman;Michael S. Niederman;Kenneth V. Leeper Jr.

  • Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

    Ethan Rubinstein;Sue K. Cammarata;Thomas H. Oliphant;Richard G. Wunderink

  • Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia

    Grant W. Waterer;Grant W. Somes;Richard G. Wunderink

  • Ventilator-associated pneumonia due to Pseudomonas aeruginosa.

    Susan Crouch Brewer;Richard G. Wunderink;Carol B. Jones;Kenneth V. Leeper

  • Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication

    Azra Bihorac;Lakhmir S. Chawla;Andrew D. Shaw;Ali Al-Khafaji

  • Community Acquired Pneumonia

    Richard G Wunderink;Grant W Waterer

  • Analysis of Two Double-Blind Studies of Patients With Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia

    Richard G. Wunderink;Jordi Rello;Sue K. Cammarata;Rodney V. Croos-Dabrera

Frequent Co-Authors

Carlos G. Grijalva
Carlos G. Grijalva Vanderbilt University Medical Center
Evan J. Anderson
Evan J. Anderson Emory University
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Jonathan A. McCullers
Jonathan A. McCullers University of Tennessee Health Science Center
Marin H. Kollef
Marin H. Kollef Washington University in St. Louis
Michael S. Niederman
Michael S. Niederman Cornell University
Jordi Rello
Jordi Rello Instituto de Salud Carlos III
Antoni Torres
Antoni Torres University of Barcelona
Andrew T. Pavia
Andrew T. Pavia University of Utah
Antonio Anzueto
Antonio Anzueto The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up more options than just traditional MD programs. Many students choose alternative online degree pathways for greater flexibility and faster career advancement. For those looking to become a registered nurse quickly, fast track medical LPN programs can provide a swift and practical entry into healthcare.

Aspiring nurses can also consider doctoral options, like DNP programs without dissertation, designed for working professionals who prefer a streamlined approach to advanced nursing practice. Mental health is another rapidly growing field. The psychiatric NP programs available online offer a flexible path for nurses aiming to specialize in psychiatric and mental health care.

For those interested in healthcare leadership, pursuing an online master of health administration can prepare you for administrative, management, or executive roles in hospitals and healthcare organizations. These non-traditional avenues can help you carve out a rewarding and impactful career in medicine.

Best Scientists Citing Richard G. Wunderink

Trending Scientists